Mathias Liljeblad

434 total citations
11 papers, 290 citations indexed

About

Mathias Liljeblad is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathias Liljeblad has authored 11 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathias Liljeblad's work include Glycosylation and Glycoproteins Research (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mathias Liljeblad is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mathias Liljeblad collaborates with scholars based in Sweden, Finland and United States. Mathias Liljeblad's co-authors include Arne Lundblad, Peter Påhlsson, Björn Carlsson, Daniel Lindén, Stefano Romeo, Rohit Loomba, Gabriella Brolén, Mikael Bjursell, Sten Ohlson and Fredrik Höök and has published in prestigious journals such as Analytical Biochemistry, Biosensors and Bioelectronics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Mathias Liljeblad

11 papers receiving 282 citations

Peers

Countries citing papers authored by Mathias Liljeblad

Since Specialization

Citations

This map shows the geographic impact of Mathias Liljeblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Liljeblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Liljeblad more than expected).

Fields of papers citing papers by Mathias Liljeblad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Liljeblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Liljeblad. The network helps show where Mathias Liljeblad may publish in the future.

Co-authorship network of co-authors of Mathias Liljeblad

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Liljeblad. A scholar is included among the top collaborators of Mathias Liljeblad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Liljeblad. Mathias Liljeblad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), Stergios Kechagias, Sara Hansson, Mathias Liljeblad, Patrik Nasr, Björn Carlsson, Mattias Ekstedt, Sebastian Ueckert	2
2	Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans 2022 ·Hepatology Communications ·Elke Ericson, (unknown), Anne‐Christine Andréasson, Carly I. Dix, (unknown), Sara Hansson, Richard Lee, Jennifer Schumi, Madeleine Antonsson, Ola Fjellström, Patrik Nasr, Mathias Liljeblad, Björn Carlsson, Stergios Kechagias, Daniel Lindén, Mattias Ekstedt	14
3	Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice 2022 ·Molecular Therapy — Nucleic Acids ·Stefano Bartesaghi, Kristina Wallenius, (unknown), Mathias Liljeblad, Simonetta Wallin, Niek Dekker, (unknown), Nigel Davies, Frank Seeliger, Maria Sörhede Winzell, Sima Patel, (unknown), (unknown), Nils Bergenhem, Shalini Andersson, Xiaorong Peng	27
4	Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis 2020 ·Alimentary Pharmacology & Therapeutics ·Björn Carlsson, Daniel Lindén, Gabriella Brolén, Mathias Liljeblad, Mikael Bjursell, Stefano Romeo, Rohit Loomba	118
5	Avidity-Based Affinity Enhancement Using Nanoliposome-Amplified SPR Sensing Enables Low Picomolar Detection of Biologically Active Neuregulin 1 2019 ·ACS Sensors ·Namık Akkılıç, Mathias Liljeblad, (unknown), Mikko Hölttä, Fredrik Höök, Stefan Geschwindner	12
6	Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry 2006 ·Journal of Chromatography B ·(unknown), (unknown), Mathias Liljeblad	36
7	Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects 2006 ·International Journal of Clinical Pharmacology and Therapeutics ·Mohammed Hassan‐Alin, Tommy Andersson, Mohammad Niazi, Mathias Liljeblad, (unknown), Kerstin Röhss	12
8	Analysis of glycoproteins in cell culture supernatants using a lectin immunosensor technique 2002 ·Biosensors and Bioelectronics ·Mathias Liljeblad, Arne Lundblad, Peter Påhlsson	20
9	A Lectin Immunosensor Technique for Determination of α1-Acid Glycoprotein Fucosylation 2001 ·Analytical Biochemistry ·Mathias Liljeblad, (unknown), Sten Ohlson, Arne Lundblad, Peter Påhlsson	18
10	Analysis of agalacto-IgG in rheumatoid arthritis using surface plasmon resonance 2000 ·Glycoconjugate Journal ·Mathias Liljeblad, Arne Lundblad, Peter Påhlsson	21
11	Detection of low-molecular-weight heparin oligosaccharides (Fragmin™) using surface plasmon resonance 1998 ·Journal of Molecular Recognition ·Mathias Liljeblad, Arne Lundblad, Sten Ohlson, Peter Påhlsson	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact